Masimo Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 5.8, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Masimo in Apr 04 2026 quarter, has decreased to 63 days, compared to 66 days, in the Jan 03 2026 quarter.

If we take a look into Healthcare sector 155 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1213, from overall ranking in the fourth quarter 2025 at 1260.

What is Receivable Turnover Ratio?
What is Masimo Corp Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MASI Receivables Turnover Ratio	(Apr 04 2026) I. Quarter	(Jan 03 2026) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter	(Mar 29 2025) I. Quarter
Y / Y Receivable Change	-11.98 %	-32.94 %	-24.1 %	-17.68 %	-17.99 %
Y / Y Revenue Change	8.28 %	-31.31 %	-26.5 %	-25.31 %	-24.5 %
Receivable Turnover Ratio (TTM)	5.8	5.52	5.52	5.55	5.67
MASI's Total Ranking	# 1213	# 1260	# 1169	# 1243	# 2196
Accounts Receivable average collection period days	63	66	66	66	64
Seq. Receivable Change	-13.45 %	-2.06 %	1.29 %	2.51 %	-34.06 %
Seq. Revenue Change	-2.54 %	11.52 %	0.08 %	-0.46 %	-38.18 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 67
Healthcare Sector	# 156
Overall Market	# 1213

Receivable Turnover Ratio Statistics
High	Average	Low
1.33	0.8	0.11
(Dec 28 2013)		(Sep 28 2013)

MASI Company Profile • Back to MASI Efficiency Comparisons • Compare MASI Receivables Turnover Ratio to its Competitors

Financial Statements
Masimo's Accounts Receivable	$ 239 Millions	Visit MASI's Balance sheet
Masimo's Sales TTM	$ 1,557 Millions	Visit MASI's Income Statement
Sources of MASI's Revenues		Visit MASI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MASI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MASI's Growth Rates	MASI's Roa	MASI's Inventory Turnover Ratio	MASI's Dividend Comparisons
MASI's Profitability Ratios	MASI's Roi	MASI's Asset Turnover Ratio	MASI's Dividend Growth
MASI's Valuation Ratios	MASI's Roe	MASI's Financial Strength Ratios	MASI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Apr 04 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Apr 04 2026	Receivable at quarter ending Apr 04 2026
China Pharma Holdings Inc	17.15	$ 3.992 Millions	$ 0.233 Millions
Nutriband Inc	16.79	$ 1.803 Millions	$ 0.107 Millions
Bioage Labs Inc	15.90	$ 10.316 Millions	$ 0.649 Millions
Arvinas Inc	15.15	$ 89.400 Millions	$ 5.900 Millions
Nurix Therapeutics Inc	15.11	$ 71.779 Millions	$ 4.750 Millions
Lexicon Pharmaceuticals Inc	14.91	$ 69.643 Millions	$ 4.670 Millions
Vaxart Inc	14.88	$ 255.609 Millions	$ 17.175 Millions
Qhslab Inc	14.80	$ 2.775 Millions	$ 0.188 Millions
Nexgel Inc	14.19	$ 10.382 Millions	$ 0.732 Millions
10x Genomics Inc	14.18	$ 637.614 Millions	$ 44.950 Millions
Sutro Biopharma Inc	14.04	$ 99.608 Millions	$ 7.095 Millions
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Skinhealth Systems Inc	13.48	$ 295.223 Millions	$ 21.902 Millions
Lftd Partners Inc	13.33	$ 36.955 Millions	$ 2.773 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Innoviva Inc	13.13	$ 394.185 Millions	$ 30.016 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Reshape Lifesciences Inc	12.79	$ 2.421 Millions	$ 0.189 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions
Clene Inc	12.47	$ 0.134 Millions	$ 0.011 Millions
Cytokinetics Incorporated	12.16	$ 105.815 Millions	$ 8.702 Millions
Teladoc Health Inc	11.94	$ 2,514.453 Millions	$ 210.660 Millions
Nrc Health	11.77	$ 138.642 Millions	$ 11.777 Millions
Option Care Health Inc	11.65	$ 5,666.577 Millions	$ 486.439 Millions

Date modified: 2026-10-05T11:03:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.